3 studies found for:    15234398 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Suspended Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary Intervention
Conditions: Myocardial Infarction;   Acute Coronary Syndromes;   Unstable Angina;   Percutaneous Coronary Intervention
Interventions: Drug: Tirofiban (Aggrastat);   Drug: Placebo
2 Completed Study of Tirofiban Administration in Patients With Aspirin and or Clopidogrel Resistance
Condition: Angioplasty, Transluminal, Percutaneous Coronary
Interventions: Drug: Tirofiban;   Drug: Placebo
3 Unknown  The Effects of Tirofiban in Diabetic Patients Undergoing Elective Percutaneous Coronary Intervention
Condition: Coronary Artery Disease
Intervention: Drug: Tirofiban

Indicates status has not been verified in more than two years